Agastiya Biotech to Bridge U.S. – India Drug Development

Dr. Baskaran Pillai announces the launch of Agastiya Biotech, a biotechnology and new drug development company based in Temecula, CA.  Prior to Agasitya Biotech, Dr. Pillai started East West Integrative Research Institute in Chennai, India in 2013, which successfully...

read more

Evaluation of Effect of Topical Application of Ps-35 on Patients Affected with Chronic Plaque Psoriasis: A Clinical Study

Psoriasis is a chronic, immune-mediated, inflammatory relapsing systemic skin disorder that predominantly involves the skin, nails, and joints with intermittent remissions. The disease is resulting from a polygenic predisposition, combined with environmental triggering factors. The worldwide prevalence of psoriasis is estimated to be approximately 2-3% [1]. Prevalence varies according to race, geographic location and environmental factors [2]. About two-thirds of affected individuals suffer from mild psoriasis, whereas about one- third have a more severe involvement.

read more